RhumbLine Advisers’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,203
| Closed | -$50.8K | – | 4239 |
|
|
2025
Q1 | $50.8K | Sell |
5,203
-571
| -10% | -$5.57K | ﹤0.01% | 3573 |
|
|
2024
Q4 | $73K | Hold |
5,774
| – | – | ﹤0.01% | 3563 |
|
|
2024
Q3 | $92.8K | Sell |
5,774
-40
| -0.7% | -$643 | ﹤0.01% | 3517 |
|
|
2024
Q2 | $142K | Buy |
5,814
+373
| +7% | +$9.1K | ﹤0.01% | 3396 |
|
|
2024
Q1 | $391K | Buy |
5,441
+124
| +2% | +$8.91K | ﹤0.01% | 2811 |
|
|
2023
Q4 | $1.06M | Buy |
5,317
+2
| +0% | +$398 | ﹤0.01% | 2218 |
|
|
2023
Q3 | $707K | Sell |
5,315
-134
| -2% | -$17.8K | ﹤0.01% | 2399 |
|
|
2023
Q2 | $815K | Buy |
5,449
+228
| +4% | +$34.1K | ﹤0.01% | 2410 |
|
|
2023
Q1 | $766K | Buy |
5,221
+788
| +18% | +$116K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $702K | Buy |
4,433
+97
| +2% | +$15.4K | ﹤0.01% | 2305 |
|
|
2022
Q3 | $835K | Buy |
4,336
+331
| +8% | +$63.7K | ﹤0.01% | 2241 |
|
|
2022
Q2 | $585K | Buy |
4,005
+1,260
| +46% | +$184K | ﹤0.01% | 2409 |
|
|
2022
Q1 | $483K | Buy |
2,745
+425
| +18% | +$74.8K | ﹤0.01% | 2438 |
|
|
2021
Q4 | $682K | Buy |
2,320
+208
| +10% | +$61.1K | ﹤0.01% | 2378 |
|
|
2021
Q3 | $525K | Buy |
2,112
+137
| +7% | +$34.1K | ﹤0.01% | 2518 |
|
|
2021
Q2 | $502K | Buy |
1,975
+681
| +53% | +$173K | ﹤0.01% | 2561 |
|
|
2021
Q1 | $230K | Sell |
1,294
-106
| -8% | -$18.8K | ﹤0.01% | 2797 |
|
|
2020
Q4 | $221K | Buy |
1,400
+154
| +12% | +$24.3K | ﹤0.01% | 2799 |
|
|
2020
Q3 | $321K | Sell |
1,246
-240
| -16% | -$61.8K | ﹤0.01% | 2487 |
|
|
2020
Q2 | $345K | Buy |
+1,486
| New | +$345K | ﹤0.01% | 2512 |
|